The evolving view of coronary artery calcium and cardiovascular disease risk

Isac C Thomas1,2, Nketi I Forbang2, Michael H Criqui2

  • 1Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego.

Clinical Cardiology
|January 23, 2018
PubMed

Insights

Coronary artery calcium (CAC) scoring may need reevaluation. Higher CAC density appears protective against cardiovascular disease (CVD) events, challenging traditional risk assessment models.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Medical Imaging Analysis

Background:

  • Coronary artery calcification (CAC) is linked to atherosclerosis and used in cardiovascular disease (CVD) risk assessment.
  • Traditional CAC quantification (Agatston units) assumes higher density and area indicate greater risk.
  • Emerging evidence suggests CAC may have protective aspects influencing future CVD risk.

Purpose of the Study:

  • To re-evaluate the prognostic value of coronary artery calcium (CAC) in cardiovascular disease (CVD) risk assessment.
  • To investigate the role of CAC density and plaque characteristics in modulating CVD risk.
  • To explore potential plaque stabilization effects of vascular calcification.

Main Methods:

  • Analysis of existing research and findings from studies like the Multi-Ethnic Study of Atherosclerosis (MESA).
  • Review of studies using intracoronary ultrasound and coronary computed tomography angiography.
  • Examination of the relationship between CAC quantification, plaque characteristics, and CVD events.

Main Results:

  • Higher CAC density, contrary to previous assumptions, may be protective against coronary heart disease and CVD events.
  • Calcified atherosclerotic plaque is associated with fewer CVD events compared to noncalcified or sparsely calcified plaque.
  • Statins may be associated with increased CAC, despite their proven CVD benefits.

Conclusions:

  • Current CAC quantification methods may require refinement.
  • Vascular calcification's role in plaque stabilization warrants further investigation.
  • CAC possesses underappreciated aspects that can modulate and potentially attenuate future CVD risk, necessitating a revised approach to risk assessment.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
430
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
588